Research Topics
| G StuderSummaryAffiliation: University Hospital Country: Switzerland Publications
| Collaborators
|
Detail Information
Publications
Dysphagia in head and neck cancer patients following intensity modulated radiotherapy (IMRT)Evangelia Peponi
Department of Radiation Oncology, University Hospital Zurich, Zurich, Switzerland
Radiat Oncol 6:1. 2011....- PET/CT staging followed by Intensity-Modulated Radiotherapy (IMRT) improves treatment outcome of locally advanced pharyngeal carcinoma: a matched-pair comparisonSacha Rothschild
Center for Clinical Research, Zurich University Hospital, Ramistrasse 100, 8091, Zurich, Switzerland
Radiat Oncol 2:22. 2007.... - Down regulation of E-Cadherin (ECAD) - a predictor for occult metastatic disease in sentinel node biopsy of early squamous cell carcinomas of the oral cavity and oropharynxGerhard F Huber
Otorhinolaryngology, Head and Neck Surgery, University Hospital Zurich, Switzerland
BMC Cancer 11:217:1-8. 2011..The E-Cadherin glycoprotein is an intercellular adhesion molecule in epithelial cells, which plays an important role in establishing and maintaining intercellular connections... - Impact of tumor volume and systemic therapy on outcome in patients undergoing IMRT for large volume head neck cancerGabriela Studer
Department of Radiation Oncology, University Hospital Zurich, Raemistrasse 100, 8091 Zurich, Switzerland
Radiat Oncol 6:120. 2011..0001).The aim of this report was to analyze whether there is a subgroup out of patients with tGTV > 70 cc, which only marginally benefits from intensive curative treatment... - Volumetric staging (VS) is superior to TNM and AJCC staging in predicting outcome of head and neck cancer treated with IMRTG Studer
Department of Radiation Oncology, University Hospital, Zurich, Switzerland
Acta Oncol 46:386-94. 2007..GTV represented the most important prognostic indicator in HNC treated with IMRT and is recommended to be considered for therapeutic decisions and estimation of outcome... - Surviving hypopharynx-larynx carcinoma in the era of IMRTGabriela Studer
Department of Radiation Oncology, Head and Neck Surgery, University Hospital Zurich, Zurich, Switzerland
Int J Radiat Oncol Biol Phys 77:1391-6. 2010..Considering the lack of standardization in prescription dose for intensity-modulated radiotherapy (IMRT), we aimed to compare the results after our methods of simultaneously integrated boost IMRT with published results... - Locoregional failure analysis in head-and-neck cancer patients treated with IMRTGabriela Studer
Department of Radiation Oncology, University Hospital, Zurich, Switzerland
Strahlenther Onkol 183:417-23; discussion 424-5. 2007.... - [Recommendations for dental care prior to intensity-modulated radiotherapy (IMRT). Adaptation of the University Hospital Zurich (USZ) guidelines]Gabriela Studer
Klinik und Poliklinik für Radio Onkologie, Universitatsspital Zurich
Schweiz Monatsschr Zahnmed 117:637-47. 2007..The depicted sketches (Fig. 2) are thought to get completed by the radiation oncologist, in order to inform the dentist about topographic risk areas/levels for radiation-induced late effects... - Prediction of distant metastasis in head neck cancer patients: implications for induction chemotherapy and pre-treatment staging?Gabriela Studer
Department of Radiation Oncology, University Hospital Zurich, Zurich, Switzerland
Strahlenther Onkol 184:580-5. 2008..In order to define a more efficient selection of patients at risk for DM with respect to IC and M-staging, we analysed our patients treated by contemporary standards... - Outcome in recurrent head neck cancer treated with salvage-IMRTGabriela Studer
Department of Radiation Oncology, University Hospital Zurich, Zurich, Switzerland
Radiat Oncol 3:43. 2008..The purpose of this work was to analyse our rHNC subgroup treated with salvage-intensity modulated radiation therapy (IMRT) for curable recurrence after initial surgery alone... - Grade 3/4 dermatitis in head and neck cancer patients treated with concurrent cetuximab and IMRTGabriela Studer
Department of Radiation Oncology, University Hospital Zurich, Zurich, Switzerland
Int J Radiat Oncol Biol Phys 81:110-7. 2011..We hypothesized a positive association between the radiation dose to the skin and the degree of dermatitis in patients receiving cetuximab... - IMRT in oral cavity cancerGabriela Studer
Department of Radiation Oncology, University Hospital Zurich, Ramistrasse 100, 8091 Zurich, Switzerland
Radiat Oncol 2:16. 2007..In addition, comparisons were performed between this IMRT OCC cohort and historic in-house cohorts of 33 conventionally irradiated (3DCRT) and 30 surgery only patients treated over the last 10 years... - Postoperative IMRT in head and neck cancerGabriela Studer
Radiation Oncology, University Hospital Zurich, Ramistrasse 100, 8091 Zurich, Switzerland
Radiat Oncol 1:40. 2006..Mean and median follow up was 19 months (2-48), and 17.6 months. 83% were treated with IMRT-chemotherapy. Mean prescribed dose was 66.3 Gy (60-70), delivered with doses per fraction of 2-2.3 Gy, respectively... - Osteoradionecrosis of the mandibula in patients treated with different fractionationsGabriela Studer
Department of Radiation Oncology, University Hospital Zurich, Switzerland
Strahlenther Onkol 180:233-40. 2004.... - Risk-adapted dental care prior to intensity-modulated radiotherapy (IMRT)Gabriela Studer
Clinic for Radiation Oncology, University Hospital Zurich, Zurich, Switzerland
Schweiz Monatsschr Zahnmed 121:216-29. 2011..The aim of the present study was therefore to evaluate the efficacy of RaDC as reflected by the ORN rate of our IMRT patients... - Osteoradionecrosis of the mandible: minimized risk profile following intensity-modulated radiation therapy (IMRT)Gabriela Studer
Department of Radiation Oncology, University Hospital, Zurich, Switzerland
Strahlenther Onkol 182:283-8. 2006..The aim of this descriptive study was to assess absolute and relative bone volumes exposed to high IMRT doses, related to observed bone tolerance... - IMRT in hypopharyngeal tumorsGabriela Studer
Radiotherapie, USZ, Universitatsspital Zurich, Ramistrasse 100, 8091, Zurich, Switzerland
Strahlenther Onkol 182:331-5. 2006..In this study, the authors report on early results in an own HC patient cohort treated with IMRT. A more favorable outcome as compared to historical data on conventional radiation techniques was expected... - IMRT using simultaneously integrated boost (SIB) in head and neck cancer patientsG Studer
Department of Radiation Oncology, University Hospital, Zurich, Switzerland
Radiat Oncol 1:7. 2006..The aim of this work was (1) to establish tumor response in HNC patients treated with SIB-IMRT, and (2) to assess tissue tolerance following different SIB-IMRT schedules... - Outcome of patients after treatment for a squamous cell carcinoma of the oropharynxChristof Roosli
Clinic of Otorhinolaryngology Head and Neck Surgery, University Hospital Zurich, Zurich, Switzerland
Laryngoscope 119:534-40. 2009..This study evaluates the oncologic outcome with regard to survival and locoregional tumor control in a cohort of patients with oropharyngeal squamous cell carcinoma (OPSCC) treated according to a uniform algorithm... - Salvage treatment for recurrent oropharyngeal squamous cell carcinomaChristof Roosli
Clinic of Otorhinolaryngology, Head and Neck Surgery, University Hospital Zurich, Zurich, Switzerland
Head Neck 32:989-96. 2010.... - Clinical outcome after treatment with a brachytherapy boost versus external beam boost for anal carcinomaChristoph Oehler Janne
Radiation Oncology, Zurich University Hospital, Zurich, Switzerland
Brachytherapy 6:218-26. 2007..To evaluate the outcome after definitive whole pelvis external beam radiotherapy (EBRT) followed by brachytherapy (BT) boost after treatment break vs. external beam boost without break in the treatment of anal carcinoma... - Quality of life and psychiatric morbidity in patients successfully treated for oral cavity squamous cell cancer and their wivesRoger A Zwahlen
University Hospital, Zurich, Switzerland
J Oral Maxillofac Surg 66:1125-32. 2008..To assess quality of life (QOL) and psychiatric morbidity in successfully treated oral cavity squamous cell cancer (OC-SCC) survivors and their wives... - Outcomes and patterns of failure in solitary plasmacytoma: a multicenter Rare Cancer Network study of 258 patientsMahmut Ozsahin
Department of Radiation Oncology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
Int J Radiat Oncol Biol Phys 64:210-7. 2006..To assess the outcomes and patterns of failure in solitary plasmacytoma (SP)... - Early improvements in vision after fractionated stereotactic radiotherapy for primary optic nerve sheath meningiomaBrigitta G Baumert
Radiation Oncology, University Hospital Zurich, Zurich, Switzerland
Radiother Oncol 72:169-74. 2004..CONCLUSIONS: Fractionated stereotactic radiotherapy improves vision, often shortly after treatment, and is thus a viable treatment option for this tumour entity... - In response to Dr. Merav A. Ben-David et al. ("Lack of osteoradionecrosis of the mandible after IMRT," Int J Radiat Oncol Biol Phys 2007:In Press)Gabriela Studer
Int J Radiat Oncol Biol Phys 68:1583-4. 2007 - In regards to Dr. Garden et al. (Int J Radiat Oncol Biol Phys 2007;67:438-444)Gabriela Studer
Int J Radiat Oncol Biol Phys 68:313-4. 2007 - Outcome and prognostic factors in orbital lymphoma: a Rare Cancer Network study on 90 consecutive patients treated with radiotherapySylvie Martinet
Centre Hospitalier Universitaire Vaudois (CHUV, Lausanne, Switzerland
Int J Radiat Oncol Biol Phys 55:892-8. 2003..A full staging workup is warranted in these patients. Prognostic factors were identified that could be useful in the overall management of this uncommon site of primary lymphoma... - Outcome and patterns of failure in testicular lymphoma: a multicenter Rare Cancer Network studyAbderrahim Zouhair
Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
Int J Radiat Oncol Biol Phys 52:652-6. 2002..More effective CNS prophylaxis, including combined modalities, should be prospectively explored in this uncommon site of extranodal lymphoma... - The curative role of radiotherapy in adenocarcinoma of the prostate in patients under 55 years of age: a rare cancer network retrospective studyTan Dat Nguyen
Department of Radiation Oncology, Institut Jean Godinot, Reims, France
Radiother Oncol 77:286-9. 2005..Our results suggest that similar local control in younger and older patients can be expected from either external beam radiotherapy or radical prostatectomy... - [Prostate cancer diagnosed before 55: a retrospective study from the Rare Cancer Network]Tan Dat Nguyen
Institut Jean-Godinot (IJG, , BP 171, 51000 Reims
Bull Cancer 91:959-64. 2004..Therefore, a complete information on morbidity associated to the different means of treatment would lead to a better acceptance of late side effects...